Donald M Orourke, MD | |
3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104 | |
(215) 662-3487 | |
Not Available |
Full Name | Donald M Orourke |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 37 Years |
Location | 3400 Spruce St, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922036029 | NPI | - | NPPES |
0018333400001 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD042739E (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Penn Medicine Home Health | Bala cynwyd, PA | Home health agency |
Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
Pennsylvania Hospital | Philadelphia, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
A new strain of norovirus known as Sydney 2012 has caused a significant number of acute outbreaks of the infection during the 2012–2013 winter season and continues to spread worldwide.
Dentists in Britain say children should not brush their teeth after every meal, they say it may be doing their teeth more harm than good.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.
› Verified 5 days ago
Entity Name | University Of Penn - Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
A new strain of norovirus known as Sydney 2012 has caused a significant number of acute outbreaks of the infection during the 2012–2013 winter season and continues to spread worldwide.
Dentists in Britain say children should not brush their teeth after every meal, they say it may be doing their teeth more harm than good.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Donald M Orourke, MD 3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104-4206 Ph: () - | Donald M Orourke, MD 3400 Spruce St, 3 Silverstein Bldg, Philadelphia, PA 19104 Ph: (215) 662-3487 |
News Archive
A new strain of norovirus known as Sydney 2012 has caused a significant number of acute outbreaks of the infection during the 2012–2013 winter season and continues to spread worldwide.
Dentists in Britain say children should not brush their teeth after every meal, they say it may be doing their teeth more harm than good.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.
› Verified 5 days ago
Xun Li, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-316-5151 | |
Dr. Ahmet Fatih Atik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Cotton St, Philadelphia, PA 19127 Phone: 215-892-7600 | |
Dr. Srinivasa Prasad Venkata Kanuparthi, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 | |
John Y Lee, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 3 Silverstein Bldg, Philadelphia, PA 19104 Phone: 215-662-3487 | |
Dr. Nduka Mgbechinyere Amankulor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Civic Center Blvd, 2nd Flr South Pavilion, Philadelphia, PA 19104 Phone: 215-662-3487 Fax: 215-349-5534 | |
Kareem Amir Zaghloul, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104 Phone: 215-662-3957 | |
Dr. Bong-soo Kim, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3509 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 |